Cryptosporidiosis in HIV-seropositive patients

C Blanshard1, A M Jackson, D C Shanson

  • 1HIV/GUM Unit, Westminster Hospital, London.

Insights

Cryptosporidiosis in HIV patients presents with varied clinical patterns, including transient, chronic, and fulminant disease. Survival is significantly impacted by disease severity and CD4 counts, with zidovudine being the only effective treatment.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Gastroenterology

Background:

  • Cryptosporidiosis incidence is rising in HIV-infected individuals, particularly those with AIDS.
  • A significant seasonal variation in cryptosporidiosis cases has been observed.
  • The disease course in Human Immunodeficiency Virus (HIV) patients is not fully understood.

Purpose of the Study:

  • To investigate the clinical patterns and outcomes of cryptosporidiosis in HIV-infected patients.
  • To identify factors influencing disease severity and patient survival.
  • To understand the heterogeneity of cryptosporidiosis in this population.

Main Methods:

  • Retrospective study of 128 HIV-infected patients diagnosed with cryptosporidiosis.
  • Classification of disease into four clinical patterns: transient, chronic, fulminant, and asymptomatic.
  • Analysis of CD4 lymphocyte counts, weight loss, and co-infections.

Main Results:

  • Four clinical patterns identified: transient (28.7%), chronic (59.7%), fulminant (7.8%), and asymptomatic (3.9%).
  • Fulminant disease (stool >2L/day) occurred in patients with CD4 <50/mm3, significant weight loss, and other infections, with a median survival of 5 weeks.
  • Survival varied by pattern: transient (36 weeks), chronic (20 weeks), and fulminant (5 weeks). Zidovudine was the only treatment impacting survival.

Conclusions:

  • Cryptosporidiosis in HIV-infected individuals is a heterogeneous disease with distinct clinical presentations.
  • CD4 count is a critical determinant of disease severity and prognosis.
  • Fulminant cryptosporidiosis carries a poor prognosis, highlighting the need for effective management strategies.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...